EP 4213937 A1 20230726 - SOLID DOSAGE FORM COMPRISING SITAGLIPTIN AND METHOD OF PREPARATION THEREOF
Title (en)
SOLID DOSAGE FORM COMPRISING SITAGLIPTIN AND METHOD OF PREPARATION THEREOF
Title (de)
FESTE DARREICHUNGSFORM MIT SITAGLIPTIN UND VERFAHREN ZUR HERSTELLUNG DAVON
Title (fr)
FORME POSOLOGIQUE SOLIDE COMPRENANT DE LA SITAGLIPTINE ET SON PROCÉDÉ DE PRÉPARATION
Publication
Application
Priority
- GR 20200100560 A 20200915
- EP 2021025344 W 20210914
Abstract (en)
[origin: WO2022058044A1] The present invention relates to a solid dosage form useful for the treatment of Type 2 diabetes. The main objective of the present invention is to provide tablets formulation comprising Sitagliptin or a pharmaceutically acceptable salt thereof that is robust and stable. An effective manufacturing process for the preparation of said tablets is also provided.
IPC 8 full level
A61P 3/00 (2006.01); A61K 9/20 (2006.01); A61K 31/4985 (2006.01)
CPC (source: EP GR)
A61K 9/1652 (2013.01 - GR); A61K 9/2054 (2013.01 - EP GR); A61K 9/2095 (2013.01 - EP); A61K 31/4985 (2013.01 - EP GR); A61P 3/00 (2017.12 - EP); A61P 3/10 (2017.12 - GR)
Citation (search report)
See references of WO 2022058044A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022058044 A1 20220324; EP 4213937 A1 20230726; GR 1010089 B 20210927
DOCDB simple family (application)
EP 2021025344 W 20210914; EP 21782434 A 20210914; GR 20200100560 A 20200915